SEC Form 4 · accession 0001493152-17-007777
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond F Schinazi
Director · 10% Owner
Period of report
Jul 11, 2017
Accepted (ET)
Jul 13, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 11, 2017 | M | 1,706,978 | $0.047 | A | 277,227,831 | D | |
| Common Stock | holding | — | — | — | 9,044,717 | I | By LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $0.047 | Jul 11, 2017 | M | 1,706,978 | D | Nov 25, 2014 | Jan 2, 2018 | Common Stock | 1,706,978 | 0 | D |